Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02024579
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
PRR | 3-(METHYL-PYRIDINIUM)ALANINE | H,I,J | 7KME | 0.71 | |
IAG | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | A,B | 1K8Z | 0.7 | |
IAG | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | A,B | 1K7E | 0.7 | |
DTR | D-TRYPTOPHAN | A,B,C,D | 2R3C | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1XY8 | 0.7 | |
DTR | D-TRYPTOPHAN | A,B,C,H,K,L | 2R5D | 0.7 | |
DTR | D-TRYPTOPHAN | A | 2V7K | 0.7 | |
DTR | D-TRYPTOPHAN | A,D | 1CZQ | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1DFY | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1XY5 | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1NXN | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1TKF | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1YL9 | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1XXZ | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1XY4 | 0.7 | |
DTR | D-TRYPTOPHAN | A,D | 2Q3I | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1QFB | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1DFZ | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1XY9 | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1XY6 | 0.7 | |
DTR | D-TRYPTOPHAN | A | 2SOC | 0.7 | |
DTR | D-TRYPTOPHAN | A | 2JUE | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1SOC | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1YL8 | 0.7 | |
DTR | D-TRYPTOPHAN | A,B,C,D,E,F, G,H | 1DDO | 0.7 | |
DTR | D-TRYPTOPHAN | A,B | 2Q33 | 0.7 | |
DTR | D-TRYPTOPHAN | A | 1DG0 | 0.7 | |
DTR | D-TRYPTOPHAN | A,B,C,H,K,L | 2R5B | 0.7 | |
SU1 | 3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL- 2-YL)METHYLENE]-2-INDOLINONE | A,B | 1FGI | 0.72 | |
2S8 | (2S)-8-[(tert-butoxycarbonyl)amino]- 2-(1H-indol-3-yl)octanoic acid | B | 3C6N | 0.71 | |
U73 | N-(5-ISOPROPYL-THIAZOL-2-YL)-2- PYRIDIN-3-YL-ACETAMIDE | A | 2BTR | 0.71 | |
SRS | 4-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.0(13,18)]NONADECA- 12(19),13(18),15,17-TETRAENE-10- CARBAMOYL)PENTA-METHYLSULFONEDIIMINE | A | 1MMR | 0.72 | |
TRF | N1-FORMYL-TRYPTOPHAN | A,B | 1VRK | 0.71 | |
TRF | N1-FORMYL-TRYPTOPHAN | A,B,C,D | 1QS7 | 0.71 | |
MZ5 | (2S)-N-[(1S,2R)-3-{(1,3-BENZOTHIAZOL- 6-YLSULFONYL)[(2S)-2-METHYLBUTYL]AMINO}- 1-BENZYL-2-HYDROXYPROPYL]-2-HYDROXY- 3-METHYLBUTANAMIDE | A,B | 2QI3 | 0.74 | |
N12 | N-[(1R)-2-[(1-{[({6-[AMINO(IMINO)METHYL]PYRIDIN- 3-YL}METHYL)AMINO]CARBONYL}CYCLOPENTYL)AMINO]- 1-(CYCLOHEXYLMETHYL)-2-OXOETHYL]GLYCINE | H,P | 2ANK | 0.74 | |
1CM | (2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE | A | 2CI0 | 0.71 | |
3NA | {3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL- 2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID | A | 1Z3N | 0.7 | |
PYA | 3-(1,10-PHENANTHROL-2-YL)-L-ALANINE | A | 1HCW | 0.71 | |
DPS | 3-(1H-INDOL-3-YL)-2-[4-(4-PHENYL- PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]- PROPIONIC ACID | A | 1CAQ | 0.7 | |
DPS | 3-(1H-INDOL-3-YL)-2-[4-(4-PHENYL- PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]- PROPIONIC ACID | A | 1CIZ | 0.7 | |
IAC | 1H-INDOL-3-YLACETIC ACID | B | 2P1Q | 0.7 | |
IAC | 1H-INDOL-3-YLACETIC ACID | A | 2OYF | 0.7 | |
IAC | 1H-INDOL-3-YLACETIC ACID | A,B | 3FVU | 0.7 | |
IAC | 1H-INDOL-3-YLACETIC ACID | B | 2P1P | 0.7 | |
IAV | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | A,B | 1K7F | 0.72 | |
737 | N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)- BUTYL]-2-{6-OXO-5-[(QUINOLIN-8- YLMETHYL)-AMINO]-2-M-TOLYL-6H-PYRIMIDIN- 1-YL}-ACETAMIDE | A | 1ZTL | 0.7 | |
RSS | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA- 12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)- HEXANOIC ACID | A,B | 1MMP | 0.75 | |
I10 | 1-[2-(3-BIPHENYL)-4-METHYLVALERYL)]AMINO- 3-(2-PYRIDYLSULFONYL)AMINO-2-PROPANONE | A | 1BGO | 0.71 | |
CDO | 2-((R)-1-((S)-2-(N-(6-CARBAMIMIDOYLPYRIDIN- 3-YL)METHYLCARBAMOYL)-2H-PYRROL- 1(5H)-YL)-3-CYCLOHEXYL-1-OXOPROPAN- 2-YLAMINO)ACETIC ACID | H | 2ANM | 0.74 | |
MN8 | 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE | N | 1NLP | 0.73 | |
PF3 | (2R)-3-({[4-[(PYRIDIN-4-YL)PHENYL]- THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID | A,B | 1UTZ | 0.81 | |
2S2 | (2S)-2-(1H-indol-3-yl)hexanoic acid | B | 3C6O | 0.71 | |
IOP | INDOLYLPROPIONIC ACID | A,B | 1AHF | 0.71 | |
IOP | INDOLYLPROPIONIC ACID | A | 2OLI | 0.71 | |
IOP | INDOLYLPROPIONIC ACID | A,B | 2AY5 | 0.71 | |
MPE | (1H-INDOL-3-YL)-(2-MERCAPTO-ETHOXYIMINO)- ACETIC ACID | A | 1M4A | 0.71 | |
2S3 | (2S)-2-(1H-indol-3-yl)pentanoic acid | B | 3C6P | 0.71 | |
3IB | 3-INDOLEBUTYRIC ACID | A,B | 2AY6 | 0.72 | |
3IB | 3-INDOLEBUTYRIC ACID | A,B,C,E | 2GJ6 | 0.72 | |
MZ7 | N~2~-ACETYL-N-{(1S,2R)-3-[(1,3- BENZOTHIAZOL-6-YLSULFONYL)(PENTYL)AMINO]- 1-BENZYL-2-HYDROXYPROPYL}-L-VALINAMIDE | A,B | 2QI5 | 0.73 | |
IAD | N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID | A,B | 1K3U | 0.71 | |
4PP | C,L | 1XKA | 0.72 | ||
4PP | A,B,C,D | 1XKB | 0.72 | ||
ITR | IMINO-TRYPTOPHAN | A,B,C,D,E,F, G,H | 1DDO | 0.71 | |
CII | N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide | A | 2W0A | 0.7 | |
PPX | [PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN- 4-YLAMINO)-ETHYL]-AMINE | E,H | 1QBV | 0.72 | |
RIT | RITONAVIR | A,B | 2B60 | 0.71 | |
RIT | RITONAVIR | B,D | 1N49 | 0.71 | |
RIT | RITONAVIR | A | 1RL8 | 0.71 | |
RIT | RITONAVIR | B | 1SH9 | 0.71 | |
RIT | RITONAVIR | B | 1HXW | 0.71 | |
C48 | N1-(1-DIMETHYLCARBAMOYL-2-PHENYL- ETHYL)-2-OXO-N4-(2-PYRIDIN-2-YL- ETHYL)-SUCCINAMIDE | A | 1CVZ | 0.72 | |
32T | (S)-2-AMINO-3-(4H-THIENO[3,2-B]- PYRROL-6-YL)-PROPIONIC ACID | A | 1RMO | 0.76 | |
BP5 | 3-(2,2'-BIPYRIDIN-5-YL)-L-ALANINE | A | 2PXH | 0.73 | |
N3T | A,B | 1TKA | 0.72 | ||
685 | 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin- 4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]- 4-methyl-1,3-thiazole-5-carboxamide | A | 3EMG | 0.72 | |
698 | (2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)- 2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE- 2,4-DICARBOXYLIC ACID | A,B | 2JC1 | 0.7 | |
NPH | CYSTEINE-METHYLENE-CARBAMOYL-1,10- PHENANTHROLINE | A | 1A18 | 0.72 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDI | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDX | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DUX | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 1MAR | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DV0 | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDM | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDB | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PD5 | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2FZ9 | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2DUZ | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2PDF | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HVO | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HVN | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2FZ8 | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 2HV5 | 0.7 | |
ZST | 3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL- 2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID | A | 1FRB | 0.7 | |
CM9 | CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)- 1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE | A | 2W09 | 0.75 | |
BTH | 4-OXO-3-{6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}- PENTANOIC ACID | A | 1RWO | 0.71 | |
Y27 | (R)-TRANS-4-(1-AMINOETHYL)-N-(4- PYRIDYL) CYCLOHEXANECARBOXAMIDE | A | 2GNF | 0.7 | |
Y27 | (R)-TRANS-4-(1-AMINOETHYL)-N-(4- PYRIDYL) CYCLOHEXANECARBOXAMIDE | A | 2H9V | 0.7 | |
Y27 | (R)-TRANS-4-(1-AMINOETHYL)-N-(4- PYRIDYL) CYCLOHEXANECARBOXAMIDE | A,B | 2ETR | 0.7 | |
Y27 | (R)-TRANS-4-(1-AMINOETHYL)-N-(4- PYRIDYL) CYCLOHEXANECARBOXAMIDE | A | 2GNJ | 0.7 | |
Y27 | (R)-TRANS-4-(1-AMINOETHYL)-N-(4- PYRIDYL) CYCLOHEXANECARBOXAMIDE | A | 1Q8T | 0.7 | |
180 | 2-(S)-[N-(3-PYRIDYLSULFONYL)AMINO]- 3-[[2-CARBONYL-5-[2-(PIPERIDIN- 4-YL)ETHYL]-THIENO[2,3-B]THIOPHENEYL]AMINO]- PROPIONIC ACID | A,B | 2VC2 | 0.71 | |
NA9 | N-(CARBOXYMETHYL)-3-CYCLOHEXYL- D-ALANYL-N-({6-[AMINO(IMINO)METHYL]PYRIDIN- 3-YL}METHYL)-N~2~-METHYL-L-ALANINAMIDE | H,P | 2A2X | 0.74 |